RHONDA CAMPBELL: Open Payments
NPI 1255779328 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 20 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $234 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| Daiichi Sankyo Inc. | 3 | $70 |
| PFIZER INC. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $51 |
| Incyte Corporation | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: DATROWAY, PLUVICTO, ERLEADA, ENHERTU, IBRANCE, LYNPARZA, MONJUVI, Vanflyta.
Industry payments across GA — which companies pay providers there.
